Association between health related quality of life and severity of depression in patients with major depressive disorder

Journal of Central South University (Medical Sciences)

Volumn 36, Issue 2, 2011, Pages 143-148

  Cao, Yuping ^a   Li, Wen ^b   Shen, Jingjin ^a,c   Zhang, Yalin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Mental Hospital   (China)

^c Shenzhen Sixth Hospital   (China)

Author keywords

Correlation; Health related quality of life; Major depressive disorder; Prospective; Severity

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; COGNITIVE DEFECT; FEMALE; HEALTH STATUS; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 79952972940     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2011.02.009     Document Type: Article

References (18)

1. Papakostas G I, Petersen T, Mahal Y, et al. Quality of life assessments in major depressive disorder: a review of the litera-ture[J].Gen Hosp Psychiatry, 2004, 26(1):13-17. (Pubitemid 38142561)
2. Murray C J, Lopez A D. Global mortality, disability, and the contribution of risk factors: global burden of disease study[J], Lancet, 1997, 349(9063): 1436-1442. (Pubitemid 27212192)
3. Murray C J, Lopez A D. Alternative projections of mortality and disability by cause, 1990-2020: global burden of disease study[J]. Lancet, 1997,349(9064) :1498-1504. (Pubitemid 27216360)
4. Hays R D, Wells K B, Sherboume CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses [ J ]. Arch Gen Psychiatry, 1995,52(1); 11-19.
5. Demyttenaere K, de Fruyt J, Huygens R. Measuring quality of life in depression[ J], Curr Opin Psychiatry, 2002,15(1) :89-92.
6. FANG Jiqian, HAOYuantao. Healthsurveyquestionnaire (SF-36) [J].Chinese Journal of Behavioral Medical Science, 2001,10:19-24.
7. ZHANG Shaoping, WANG Zuowei, CHEN Yindi.et al. Using and evaluation of Health Survey Questionnaire in patient with depression [ J ]. Chinese Journal of Behavioral Medical Science,2006, 15(10):944.
8. ZHANG Mingyuan. Manual of psychiatric rating scales[M]. 2nd ed. Changsha; Hunan Science & Technology Press, 2003: 121-126,150-153.
9. Aydemir O, Ergtln H, Soygur H, et al. Quality of life in major depressive disorder: A cross-sectional study[J] Turkish J Psychiatry, 2009, 20, 3: 205-212
10. Patten S B, Kennedy S H, Lam R W,et al. Canadian network for mood and anxiety treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management[J]. J Affect Disord, 2009,117 (Suppl 1):S5-S14.
11. Saarijarvi S, Salminen J K, Toikka T, et al. Health-related quality of life among patients with major depression [ J ]. Nord J Psychiatry, 2002, 56(4) :261-264.
12. Breslau N, Schultz L R, Stewart W F, et al. Headache and major depression; is the association specific to migraine? [J]. Neurology, 2000, 54(2) :308-313. (Pubitemid 30078058)
13. Upton R B, Hamelsky S W, Kolodner KB, et al. Migraine, quality of life, and depression: a population-based case-control study[J]. Neurology, 2000, 55(5): 629-635.
14. Reed C, Monz B U, Perahia D G, et al. Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER[J]. J Affect Disord, 2009, 113(3) :296-302.
15. Bair M J, Robinson R L, Eckert G J, et al. Impact of pain on depression treatment response in primary care [ J ]. Psychosom Med, 2004,66(l):17-22. (Pubitemid 38146528)
16. Ruhe H G, Huyser J, Swinkels J A,et al. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review[J]. J Clin Psychiatry, 2006, 67(12):1836-1855. (Pubitemid 46055194)
17. Walker V, Streiner D L, Novosel S, et al. Health-related quality of life in patients with major depression who are treated with moclobemide[J]. J Clin Psychopharmacol, 1995, 15(4 Suppl 2): 60S-67S.
18. Quitkin F M, Rabkin J G, Stewart J W, et al. Heterogeneity of clinical response during placebo treatment [ J ]. Am J Psychiatry, 1991,148(2) :193-196.